Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| BBIO (BridgeBio Pharma, Inc.) | -11.87% | 68.15% | 62.16% | 1.59% | NA | NA | NA | … | … |
Data as of 06/10/2026, Common starting date is 06/28/2019
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| BBIO (BridgeBio Pharma, Inc.) | 06/28/2019 | 06/10/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 2.95 | 68.15 | 62.16 | 1.59 | NA | NA | NA | … | … | -11.87 | 176.24 | -30.67 | 429.79 | -54.32 | -76.54 | 102.88 | 29.96 |
| Sharpe Ratio | NA | 1.58 | 1.02 | 0.01 | NA | NA | NA | … | … | -0.53 | 3.60 | -0.68 | 4.53 | -0.56 | -0.55 | 1.24 | 0.82 |
| Standard Deviation(%) | NA | 46.50 | 62.37 | 93.84 | NA | NA | NA | … | … | 51.82 | 49.38 | 55.15 | 95.42 | 100.51 | 140.38 | 82.15 | 81.24 |
| Draw Down(%) | NA | 20.25 | 49.08 | 91.89 | NA | NA | NA | … | … | 20.25 | 19.82 | 44.75 | 31.39 | 69.64 | 84.27 | 55.53 | 44.53 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/10/2026, Common starting date is 06/28/2019
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| BBIO (BridgeBio Pharma, Inc.) |
-39.87%
Dec 2019 – Dec 2022 |
-4.78%
Dec 2019 – Dec 2024 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| BBIO (BridgeBio Pharma, Inc.) |
115.72%
Dec 2022 – Dec 2025 |
11.63%
Aug 2020 – Aug 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart